Search Results 3481-3490 of 34806 for oral

  1. Publications - Pandora K. Lee, D.M.D. - Mayo Clinic

    J Oral Implantol. 2024 Aug 1; 50 (4):328-334. View PubMed; Tran D, Deeb JG, Wojnarwsky PKL, Deeb GR. Tracking Tag Stabilization With a Small-Diameter Implant ...

  2. Mayo Clinic researchers capture first signs of ovarian cancer risk

    ... oral contraceptives may not have been effective in reducing the patient's risk for ovarian cancer. "With the generous partnership of patients who allow ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  4. Thyroid cancer - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Laryngeal cancer, Skull base tumor, Oropharyngeal cancer. Show more areas of focus for Daniel J. Ma, M.D. ...

  5. Surgery - Doctors - Mayo Clinic

    ... Oral biopsy, Microvascular surgery, Facial reconstruction, Skull base surgery, Glossectomy, Tracheostomy, Skin cancer reconstruction, Submandibular gland ...

  6. Study Using Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms - Mayo Clinic

    We propose a phase I trial with oral curcumin + piperine in older cancer to derive a safe, optimal biological dose to be tested for stent symptoms in a future ...

  7. Small bowel cancer - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

  8. Viagra for women: Does it exist? - Mayo Clinic

    For years there were no FDA-approved medicines for treating problems with sexual arousal or sexual desire in women. Yet 4 in 10 women report having sexual ...

  9. A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer - Mayo Clinic

    ... oral contraceptives. An abnormal CA-125 is defined as a level > 40 U/ml for premenopausal women who are current users of oral contraceptives. Women who ...

  10. A Registry for Participants with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection - Mayo Clinic

    ... oral SOF-based regimen outside a clinical study. These individuals must have documentation of the regimen, start and end of treatment dates (month and year) ...